Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.88
- Piotroski Score 4.00
- Grade Buy
- Symbol (KRON)
- Company Kronos Bio, Inc.
- Price $0.97
- Changes Percentage (3.2%)
- Change $0.03
- Day Low $0.97
- Day High $0.99
- Year High $1.60
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $7.63
- High Stock Price Target $13.00
- Low Stock Price Target $2.25
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.99
- Trailing P/E Ratio -0.37
- Forward P/E Ratio -0.37
- P/E Growth -0.37
- Net Income $-112,673,000
Income Statement
Quarterly
Annual
Latest News of KRON
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Krones AG's (ETR:KRN) Latest Stock Performance A Reflection Of Its Financial Health?
Krones' stock surged by 11% in the past month, prompting an analysis of its Return on Equity (ROE) to assess its financial efficiency....
By Yahoo! Finance | 2 days ago -
Fannin Jr.'s 31-yard scoring dash carries Bowling Green to 27-20 win over Akron
Bowling Green defeated Akron 27-20 with Jaison Patterson scoring two touchdowns and Harold Fannin Jr. securing the winning run. Fannin's 31-yard run sealed the victory in the fourth quarter. The Zips ...
By AP NEWS | 3 days ago -
Parker Navarro throws 2 TD passes to Coleman Owen as Ohio rolls past Akron 30-10 in MAC opener
Ohio defeated Akron 30-10 in the Mid-America Conference opener, with Parker Navarro leading the Bobcats with two touchdown passes and one rushing touchdown. Ohio's defense also contributed with a fumb...
By AP NEWS | 1 week ago
